Correlations between FEV1 and patient-reported outcomes: A pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary disease.

Donohue, James F; Jones, Paul W; Bartels, Christian; Marvel, Jessica; D'Andrea, Peter; Banerji, Donald; Morris, David G; Patalano, Francesco; Fogel, Robert

Donohue, James F; Jones, Paul W; Bartels, Christian; Marvel, Jessica; D'Andrea, Peter; Banerji, Donald; Morris, David G; Patalano, Francesco; Fogel, Robert.

Affiliation

Donohue JF; Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina, School of Medicine, Chapel Hill, NC, USA. Electronic address: jdonohue@med.unc.edu.
Jones PW; Division of Clinical Science, St George's, University of London, London, UK.
Bartels C; Novartis Pharma AG, Basel, Switzerland.
Marvel J; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
D'Andrea P; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Banerji D; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Morris DG; Novartis Pharma AG, Basel, Switzerland.
Patalano F; Novartis Pharma AG, Basel, Switzerland.
Fogel R; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.

Pulm Pharmacol Ther ; 49: 11-19, 2018 04.

Article in En | MEDLINE | ID: mdl-29277690

Subject(s)
Key words

COPD; FEV1; PROs; Regression modelling; SGRQ; TDI

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bronchodilator Agents / Pulmonary Disease, Chronic Obstructive / Patient Reported Outcome Measures Type of study: Clinical_trials / Guideline / Prognostic_studies / Qualitative_research / Systematic_reviews Aspects: Patient_preference Limits: Female / Humans / Male / Middle aged Language: En Journal: Pulm Pharmacol Ther Journal subject: FARMACOLOGIA Year: 2018 Document type: Article Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google